Previous 10 | Next 10 |
MARIETTA, Ga., July 18, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the second quarter ended June 30, 2023 after the market close on Tuesday, August 1...
2023-07-05 13:52:06 ET MiMedx ( NASDAQ: MDXG ) said Wednesday that it has appointed Doug Rice as the company's new chief financial officer. Rice will replace Pete Carlson, who has served in the CFO role since March 2020. Press Release . ...
MARIETTA, Ga., July 05, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it has appointed Doug Rice as the Company’s Chief Financial Officer, effective today. Pete Carlson, who has served in that role si...
2023-06-27 03:18:02 ET MiMedx Group ( NASDAQ: MDXG ) stock price up 4.1% to $6.35 on Monday during late hours, the company filed Form 4 that shows CEO, Joseph H. Capper buying at total of 100k shares for $640K. On June 22 and June 23, 2023, he bought 57,975 and...
2023-06-20 16:54:49 ET MiMedx Group ( NASDAQ: MDXG ) said that it was pulling the plug on its knee osteoarthritis and regenerative medicine programs in order to focus on accelerating growth for its wound and surgical business. The wound care products company, which specializes i...
Suspending Current Activities Associated with Knee Osteoarthritis Program and Disbanding Regenerative Medicine Business Unit Restructuring Expected to Generate Approximately $25 Million in Annualized Savings Raising Expectations to Deliver Mid-Teens Percentage Net Sales Growth D...
2023-05-23 08:29:22 ET CohBar ( CWBR ) +100% Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy. HeartCore Enterprises ( HTCR ) +59% Q1 earnings call rel...
2023-05-06 05:25:23 ET Summary Following the release of Q1 2023 results, MiMedx Group, Inc. shares are soaring on double-digit revenue growth and bottom line on track to turn a profit. MiMedx Group, Inc. is a Marietta, Georgia-based developer and distributor of placental tissue al...
2023-05-03 12:21:19 ET MiMedx ( NASDAQ: MDXG ) stock ~28% on Wednesday after Q1 results beat estimates. Net sales grew +21.7% Y/Y to $71.68M. Meanwhile, net loss narrowed to -$4.98M, compared to -$10.49M in Q1 2022. The company said revenue growth and cost controls helpe...
2023-05-02 23:08:05 ET MiMedx Group, Inc. (MDXG) Q1 2023 Earnings Conference Call May 02, 2023 05:00 PM ET Company Participants Matt Notarianni - Head, IR Joe Capper - CEO Pete Carlson - CFO Conference Call Participants Anthony Petrone - Mizuho Group ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-02 07:00:07 ET Ross Osborn from Cantor Fitzgerald issued a price target of $11.00 for MDXG on 2024-07-02 06:15:00. The adjusted price target was set to $11.00. At the time of the announcement, MDXG was trading at $6.7. The overall price target consensus is at $10...
MARIETTA, Ga., June 26, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the appointment of Kim Moller to Chief Commercial Officer. Ms. Moller has been serving as the Company’s Senior Vice President, Sales si...
2024-06-13 04:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...